<DOC>
	<DOCNO>NCT02738736</DOCNO>
	<brief_summary>Hypertension lead risk factor cardiovascular disease ( CVD ) globally , account 25-35 % population-attributable fraction . Sodium ( salt ) intake key determinant blood pressure , reduce sodium intake emerge important target population-based intervention prevent CVD . However , considerable uncertainty optimal level sodium intake associate low CV risk , whether optimal level differ different population individual . International national guideline recommend low sodium intake ( &lt; 2.3g/day , low ) person , advocate population-wide approach reduce sodium . Most world 's population ( ~95 % ) consume 3 6g/day sodium ( mean intake 4.0g/day ) , mean people require major change diet , achieve guideline target ( &lt; 2g/day ) . While convince evidence high sodium intake ( &gt; 5g/day ) associate increase risk CVD , compare low moderate intake , evidence low sodium intake ( &lt; 2.0g/day ) associate low risk CVD moderate intake ( 2.0-5g/day ) inconsistent inconclusive . The investigator plan conduct Phase IIb clinical trial evaluate role low sodium intake ( versus moderate ) cardiovascular biomarkers .</brief_summary>
	<brief_title>Clarifying Optimal Sodium Intake Project</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Age 40 year old Systolic blood pressure &lt; 160mmHg diastolic blood pressure &lt; 95mmHg three office blood pressure reading time screen confirm study ABPM randomization &lt; 150/90mmHg No change antihypertensive diuretic medication ( include dose ) 3 month screen visit Consumption moderate sodium intake screening , define estimate daily sodium intake &gt; 2.3/day estimate food frequency questionnaire ( FFQ ) Selfreported willingness modify dietary intake sustain period , adhere direct recommendation 2 year . Signed write informed consent Known chronic kidney disease ( CKD ) recent eGFR ≤60ml/min/1.73m2 Participants ineligible COSIP base eGFR approached enter ongoing Sodium Intake Chronic Kidney Disease ( STICK ) trial . Previous cardiovascular disease : Myocardial infarction Previous percutaneous coronary intervention ( PCI ) percutaneous transluminal coronary angioplasty ( PTCA ) Stroke ( previous transient ischaemic attack [ TIA ] exclusion criterion ) Medical diagnosis know associate abnormal renal sodium excretion , include follow : Bartter syndrome SIADH Diabetes insipidus Serum sodium &lt; 125mmol Severe heart failure define NYHA Class III/IV OR leave ventricular ejection fraction ( LVEF ) ≤30 % Highdose loop thiazide diuretic therapy , exceed total daily dose frusemide 80mg , bumetanide 2mg , hydrochlorothiazide 50mg , bendroflumethiazide 2.5mg , indapamide 2.5mg , metolazone 2.5mg use loop thiazide diuretic Unable follow educational advice research team Prescribed highsalt diet , lowsalt diet sodium bicarbonate Symptomatic postural hypotension receive treatment postural hypotension Current recent use ( within one month ) immunosuppressive medication include tacrolimus , cyclosporine , azathioprine mycophenolate mofetil Pregnancy lactation Unable comply 24hour urinary collection , medical condition make collection 24hour urinary collection difficult ( e.g . severe urinary incontinence ) Participant unlikely comply study procedure followup visit due severe comorbid illness factor ( e.g . inability travel followup visit , drug alcohol misuse ) opinion research team Cognitive impairment define know diagnosis dementia inability provide inform consent due cognitive impairment opinion investigator Body Mass Index ( BMI ) &lt; 20 kg/m2 BMI &gt; 40 kg/m2 Participating another clinical trial previous allocation study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>